Ronen Arbel
Impact in
- Virology top 5%
- Poxvirus research and outbreaks
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Diabetes Treatment and Management 20
- Diabetes Management and Research 4
-
- Atrial Fibrillation Management and Outcomes 4
- Heart Failure Treatment and Management 3
- Co-authors
- Ariel Hammerman (23 shared papers)Ruslan Sergienko (8 shared papers)Doron Netzer (12 shared papers)Shlomit Yaron (12 shared papers)Alon Peretz (8 shared papers)Michael Friger (5 shared papers)Erez Battat (8 shared papers)Yael Wolff Sagy (9 shared papers)
- Journals
- The American Journal of Cardiology (4 papers)Circulation (3 papers)The Lancet Infectious Diseases (3 papers)Nature Medicine (3 papers)American Journal of Cardiovascular Drugs (3 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Ronen Arbel
48 papers receiving 879 citations
Ronen Arbel's Hit Papers
Peers
Comparison fields: 5 of 76
- Virology 120
- Infectious Diseases 308
- Modeling and Simulation 46
- Health 60
- Endocrinology, Diabetes and Metabolism 97
Countries citing papers authored by Ronen Arbel
This map shows the geographic impact of Ronen Arbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronen Arbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronen Arbel more than expected).
Fields of papers citing papers by Ronen Arbel
This network shows the impact of papers produced by Ronen Arbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronen Arbel. The network helps show where Ronen Arbel may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronen Arbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge Hit paper breakdown → | 2022 | 209 |
| 2 | Real-world effectiveness of a single dose of mpox vaccine in males Hit paper breakdown → | 2023 | 122 |
| 3 | 2022 | 93 | |
| 4 | Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study Hit paper breakdown → | 2023 | 91 |
| 5 | 2019 | 63 | |
| 6 | 2024 | 33 | |
| 7 | 2022 | 29 | |
| 8 | 2023 | 29 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 18 | |
| 11 | 2023 | 16 | |
| 12 | 2022 | 13 | |
| 13 | 2016 | 12 | |
| 14 | 2024 | 12 | |
| 15 | 2019 | 11 | |
| 16 | 2022 | 10 | |
| 17 | 2025 | 9 | |
| 18 | 2021 | 8 | |
| 19 | 2023 | 7 | |
| 20 | 2024 | 7 |
About Ronen Arbel
Ronen Arbel is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Infectious Diseases and Molecular Biology, having authored 55 papers that have together received 895 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (20 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Pancreatic function and diabetes (6 papers), Diabetes Management and Research (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), COVID-19 Clinical Research Studies (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Heart Failure Treatment and Management (3 papers). The work is most often cited by research in Virology (120 citations), Infectious Diseases (308 citations), Modeling and Simulation (46 citations), Health (60 citations) and Endocrinology, Diabetes and Metabolism (97 citations). Ronen Arbel has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Ariel Hammerman, Ruslan Sergienko, Doron Netzer, Shlomit Yaron, Alon Peretz, Michael Friger, Erez Battat, Yael Wolff Sagy, Joseph Azuri and Gil Lavie. Their work appears in journals such as The American Journal of Cardiology, Circulation, The Lancet Infectious Diseases, Nature Medicine and American Journal of Cardiovascular Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.